Pacientes em uso de quimioterápicos: depressão e adesão ao tratamento

Abstract

This analy cal, cross-sec onal study applied a quan ta ve approach to verify the presence of depression and the adherence to a chemotherapy treatment in pa ents with cancer at the central chemotherapy pharmacy of a university hospital. The sample consisted of 102 pa ents, and data were collected from October 2010 to May 2011. A structured interview was used to obtain sociodemographic, clinical and therapeu c data; the Morisky Test and Beck Depression Inventory were also applied. The results revealed that 10.8% and 1.9% of par cipants had moderate and severe depression, respec vely. The presence of depression was signifi cantly associated with variables such as income per capita, the number of surgeries, and disease dura on. A lack of treatment adherence was iden fi ed in 48% of par cipants. These results indicate the need for health staff training to detect depressive disorders and chemotherapy treatment a ri on among pa ents with cancer.

Repercussão Da Quimioterapia No Combate Ao Câncer: A Experiência De Um Grupo Amazônico

“…As relações estabelecidas através dos diálogos individuais entre os adoecidos, e entre eles e os participantes do grupo de extensão, foram perceptíveis na articulação da dinâmica do grupo, pois pessoas que não eram tão participativas, depois de algumas reuniões se sentiam confiantes em compartilhar suas experiências e enriqueciam nosso debate com seus relatos (8) .…”

“…Quanto ao ato de ouvir, como descrevem alguns pesquisadores e como podemos evidenciar em nossa vivência, percebemos que o paciente com câncer tende a não falar sobre os seus medos e o cuidador a não questioná-lo, não associando os distúrbios do sono, a falta de apetite, queda de cabelo, perda da energia, fadiga, dor, como fatores que interferem no autocuidado, acarretando um déficit de adesão ao tratamento e agravando dessa forma o prognóstico da doença (8) .…”

Chemotherapy treatment: Colorectal cancer patients’ perception

“…In a study of 44 patients with stage IV colorectal cancer receiving chemotherapy, manifestations of toxicity, such as fatigue and insomnia, were identified. [8] Another study conducted in 102 cancer patients identified moderate and severe depression in 10.8% and 1.9%, respectively, due to the use of antineoplastic therapies [9] and therefore, founded non-adherence to treatment in 48% of patients. [9] An observational study of 100 patients with advanced colorectal cancer treated with palliative chemotherapy identified symptoms of fatigue, pain, dyspnea, and appetite loss.…”

“…[8] Another study conducted in 102 cancer patients identified moderate and severe depression in 10.8% and 1.9%, respectively, due to the use of antineoplastic therapies [9] and therefore, founded non-adherence to treatment in 48% of patients. [9] An observational study of 100 patients with advanced colorectal cancer treated with palliative chemotherapy identified symptoms of fatigue, pain, dyspnea, and appetite loss. In addition, the quality of life was deteriorated across time, thus it was found large differences between patients with and without a treatment response for pain (19.0 vs. 37.2 points) and appetite loss (17.4 vs. 32.7 points).…”

Descrição Do Apoio Social Ofertado Às Mulheres Em Tratamento Do Câncer De Mama: Importância Para O Prognóstico

“…As alterações do pensamento e do comportamento inerentes aos sintomas depressivos podem influenciar tanto somaticamente, agravando os sintomas físicos do câncer de mama quanto psicologicamente o que gera prejuízo funcional, menor adesão terapêutica, piora da qualidade de vida, pior prognóstico e consequentemente elevam as taxas de morbidade e mortalidade (SOUZA, 2013).…”